1
|
Fofi C, Festuccia F, Barberi S, Apponi F,
Chiacchiararelli L, Scopinaro F, Punzo G and Menè P: Hemodialysis
in patients requiring 131I treatment for thyroid carcinoma. Int J
Artif Organs. 36:439–443. 2013.PubMed/NCBI
|
2
|
Sherman EJ, Su YB, Lyall A, Schöder H,
Fury MG, Ghossein RA, Haque S, Lisa D, Shaha AR, Tuttle RM and
Pfister DG: Evaluation of romidepsin for clinical activity and
radioactive iodine reuptake in radioactive iodine-refractory
thyroid carcinoma. Thyroid. 23:593–599. 2013. View Article : Google Scholar : PubMed/NCBI
|
3
|
Wakabayashi H, Taki J, Inaki A, Toratani
A, Kayano D and Kinuya S: Extremity Radioactive Iodine Uptake on
Post-therapeutic Whole Body Scan in Patients with Differentiated
Thyroid Cancer. Asia Ocean J Nucl Med Biol. 3:26–34.
2015.PubMed/NCBI
|
4
|
Netea-Maier RT, Klück V, Plantinga TS and
Smit JW: Autophagy in thyroid cancer: Present knowledge and future
perspectives. Front Endocrinol (Lausanne). 6:222015.PubMed/NCBI
|
5
|
Mattick JS: RNA regulation: A new
genetics? Nat Rev Genet. 5:316–323. 2004. View Article : Google Scholar : PubMed/NCBI
|
6
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
7
|
Khalil AM, Guttman M, Huarte M, Garber M,
Raj A, Morales D Rivea, Thomas K, Presser A, Bernstein BE, van
Oudenaarden A, et al: Many human large intergenic noncoding RNAs
associate with chromatin-modifying complexes and affect gene
expression. Proc Natl Acad Sci USA. 106:11667–11672. 2009.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Tsai MC, Manor O, Wan Y, Mosammaparast N,
Wang JK, Lan F, Shi Y, Segal E and Chang HY: Long noncoding RNA as
modular scaffold of histone modification complexes. Science.
329:689–693. 2010. View Article : Google Scholar : PubMed/NCBI
|
9
|
Huang L, Liao LM, Liu AW, Wu JB, Cheng XL,
Lin JX and Zheng M: Overexpression of long noncoding RNA HOTAIR
predicts a poor prognosis in patients with cervical cancer. Arch
Gynecol Obstet. 290:717–723. 2014. View Article : Google Scholar : PubMed/NCBI
|
10
|
Kogo R, Shimamura T, Mimori K, Kawahara K,
Imoto S, Sudo T, Tanaka F, Shibata K, Suzuki A, Komune S, et al:
Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin
modification and is associated with poor prognosis in colorectal
cancers. Cancer Res. 71:6320–6326. 2011. View Article : Google Scholar : PubMed/NCBI
|
11
|
Zhang JX, Han L, Bao ZS, Wang YY, Chen LY,
Yan W, Yu SZ, Pu PY, Liu N, You YP, et al: HOTAIR, a cell
cycle-associated long noncoding RNA and a strong predictor of
survival, is preferentially expressed in classical and mesenchymal
glioma. Neuro Oncol. 15:1595–1603. 2013. View Article : Google Scholar : PubMed/NCBI
|
12
|
Thum T and Condorelli G: Long noncoding
RNAs and microRNAs in cardiovascular pathophysiology. Circ Res.
116:751–762. 2015. View Article : Google Scholar : PubMed/NCBI
|
13
|
Ling H: Non-coding RNAs: Therapeutic
Strategies and Delivery Systems. Adv Exp Med Biol. 937:229–237.
2016. View Article : Google Scholar : PubMed/NCBI
|
14
|
Latronico MV and Condorelli G: Therapeutic
applications of noncoding RNAs. Curr Opin Cardiol. 30:213–221.
2015. View Article : Google Scholar : PubMed/NCBI
|
15
|
He D, Wang J, Zhang C, Shan B, Deng X, Li
B, Zhou Y, Chen W, Hong J, Gao Y, et al: Down-regulation of
miR-675-5p contributes to tumor progression and development by
targeting pro-tumorigenic GPR55 in non-small cell lung cancer. Mol
Cancer. 14:732015. View Article : Google Scholar : PubMed/NCBI
|
16
|
Hu Y, Xu K and Yagüe E: MiR-218 targets
survivin and regulates resistance to chemotherapeutics in breast
cancer. Breast Cancer Res Treat. 151:269–280. 2015. View Article : Google Scholar : PubMed/NCBI
|
17
|
Rebucci M, Sermeus A, Leonard E, Delaive
E, Dieu M, Fransolet M, Arnould T and Michiels C: MiRNA-196b
inhibits cell proliferation and induces apoptosis in HepG2 cells by
targeting IGF2BP1. Mol Cancer. 14:792015. View Article : Google Scholar : PubMed/NCBI
|
18
|
Jin X, Sun Y, Yang H, Li J, Yu S, Chang X,
Lu Z and Chen J: Deregulation of the MiR-193b-KRAS axis contributes
to impaired cell growth in pancreatic cancer. PloS One.
10:e01255152015. View Article : Google Scholar : PubMed/NCBI
|
19
|
Kohls K, Schmidt D, Holdenrieder S, Müller
SC and Ellinger J: Detection of cell-free lncRNA in serum of cancer
patients. Urologe A. 54:819–825. 2015.(In German). View Article : Google Scholar : PubMed/NCBI
|
20
|
Li Z, Zhao X, Zhou Y, Liu Y, Zhou Q, Ye H,
Wang Y, Zeng J, Song Y, Gao W, et al: The long non-coding RNA
HOTTIP promotes progression and gemcitabine resistance by
regulating HOXA13 in pancreatic cancer. J Transl Med. 13:842015.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Yang Q, Xu E, Dai J, Liu B, Han Z, Wu J,
Zhang S, Peng B, Zhang Y and Jiang Y: A novel long noncoding RNA
AK001796 acts as an oncogene and is involved in cell growth
inhibition by resveratrol in lung cancer. Toxicol Appl Pharmacol.
285:79–88. 2015. View Article : Google Scholar : PubMed/NCBI
|
22
|
Deng L, Yang SB, Xu FF and Zhang JH: Long
noncoding RNA CCAT1 promotes hepatocellular carcinoma progression
by functioning as let-7 sponge. J Exp Clin Cancer Res. 34:182015.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Ishibashi M, Kogo R, Shibata K, Sawada G,
Takahashi Y, Kurashige J, Akiyoshi S, Sasaki S, Iwaya T, Sudo T, et
al: Clinical significance of the expression of long non-coding RNA
HOTAIR in primary hepatocellular carcinoma. Oncol Rep. 29:946–950.
2013.PubMed/NCBI
|
24
|
Yu X and Li Z: Long non-coding RNA HOTAIR:
A novel oncogene (Review). Mol Med Rep. 12:5611–5618.
2015.PubMed/NCBI
|